TSHA
Taysha Gene Therapies Inc.
$2.87
+$0.04(+1.41%)
80
Overall
--
Value
80
Tech
--
Quality
Market Cap
$774.74M
Volume
2.26M
52W Range
$1.05 - $3.40
Target Price
$8.67
EPS Estimates Overview
| Current Quarter | $-0.09 | Next Quarter | $-0.09 |
| Current Year | $-0.36 | Next Year | $-0.4 |
| QoQ Growth | +0.0% | YoY Growth | -11.1% |
| 3Y EPS CAGR | +57.4% | Target Price | $8.67 |
| Consensus | Buy | Upside | +202.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $2.87 | +1.4% | 2.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW